Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sugar tracer sheds light on brain tumors during surgery

NCT ID NCT01668082

First seen Jun 02, 2026 · Last updated Jun 23, 2026 · Updated 6 times

Summary

This study looks at how brain tumors use energy by giving patients a harmless, non-radioactive form of sugar before surgery. Researchers will analyze the tumor tissue to understand its metabolism and compare it with imaging scans and genetic tests. The goal is to learn more about tumor behavior and improve future diagnosis and treatment. About 40 people with a newly found brain mass will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Texas Southwestern

    RECRUITING

    Dallas, Texas, 75390, United States

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

13C-glucose (a non-radioactive form of sugar)

What this could lead to

If successful, this could lead to better ways to identify aggressive tumor cells and improve diagnosis and treatment planning for brain tumors.

What could go wrong

This is an early-stage observational study with only 40 participants, so results may not apply to all patients. It aims to gather knowledge, not test a treatment.

Conditions

The condition(s) this trial relates to.

brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.